The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike injections, this approach offers a less invasive way to administer GLP-1 https://sairanlfv169005.elbloglibre.com/41330868/glp-1-patches-a-new-approach-to-glucose-treatment